|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Henry Ford Health System (Drs. Joseph, Peterson, and Johnson), Detroit, MI; and Medical College of Georgia (Dr. Ownby), Augusta, GA.
Correspondence to: Christine L. M. Joseph, MD, Henry Ford Health System, Department of Biostatistics & Research Epidemiology, 1 Ford Place, 3E, Detroit, MI 48202
| Abstract |
|---|
|
|
|---|
Study objectives: To explore racial differences in physiologic factors associated with pediatric asthma severity.
Design: Cross-sectional.
Methods: We analyzed data from two groups of children in suburban Detroit, one of which contains non-urban, middle-class AA children, a group not usually included in childhood asthma studies. All children were 6 to 8 years of age. Clinical evaluations included medical history, physical examination, skin testing, spirometry, and methacholine challenge.
Results: The study population (n = 569) was 14% African American, 51% of the participants were male, and the mean age was 6.8 ± 0.4 years. Socioeconomic status (parental education) was similar overall by race, although some strata-specific differences were observed. The prevalence of physician-diagnosed asthma was 10% for both AA and EA groups. AA children were more reactive to methacholine than EA children (42% vs 22%, respectively; p = 0.001), and had significantly higher total IgE than EA children (geometric mean, 60.6 vs 27.5 IU/mL; p = 0.001). Serum IgE was related to methacholine reactivity in EA children (p = 0.001), but not AA children (p = 0.73). These differences remained after adjustment for gender, age, parental education, parental smoking, and maternal smoking during pregnancy.
Conclusions: Our data support previous reports of racial differences in lung volume, airway responsiveness, and serum IgE concentrations. We found a racial difference in the relationship between total serum IgE and airway responsiveness that is unreported elsewhere. Overall, our results suggest that AA children may be predisposed to asthma.
Key Words: asthma bronchial hyperresponsiveness IgE race
| Introduction |
|---|
|
|
|---|
The observed racial differences in asthma morbidity and mortality may reflect a difference in disease severity. Assessing differences in asthma severity is difficult since commonly used measures of severity (eg, number of emergency department visits, hospitalizations, asthma medications used, etc.) are highly influenced by social and economic factors, such as access to health care, quality of health care, referral to specialists, and health care seeking behavior.11 12 13 14 Alternatively, asthma severity can be assessed utilizing immunologic or physiologic variables. Although no single measure can determine the severity of asthma, measures of airway obstruction, airway responsiveness, total serum IgE, and allergen sensitization have been shown to be related.15 16
Previous studies addressing racial differences in asthma severity have left many unanswered questions. Most previous studies have focused on low-income, urban African Americans, albeit due to the increased morbidity observed in these populations, but it has been difficult to separate racial effects from the effects of poverty. The objective of this study was to examine immunologic and physiologic variables related to asthma severity in AA and EA children of similar socioeconomic status (SES), and residing in the same metropolitan area. By examining these variables in a multiethnic population of middle-class children, we hoped to reduce the confounding effects of SES on racial differences.
| Materials and Methods |
|---|
|
|
|---|
18 years old
belonging to the Health Alliance Plan health maintenance organization
and residing in a defined group of zip codes encompassing the northern
middle-class suburbs of Detroit, MI, were eligible if they had an
estimated delivery date between April 15, 1986, and August 31, 1989.
Research nurses recruited women during midterm prenatal visits. Only
one child per family was eligible for enrollment in the study. Race was
classified according to the self-report of the mother. Between the age
of 6 and 7 years, study children were invited to undergo their first
clinical evaluation. Because the CAS group had few AA children, a
second group, the SCAS, of approximately the same age, was recruited
from within the same geographic suburban area to undergo the identical
clinical evaluation. Recruitment focused on Southfield, MI, a
particular suburb within the CAS study area that has a more multiethnic
population. According to the 1990 census, AA residents in Southfield
have a SES comparable to that of the parents of the children in the CAS
cohort. Children were eligible for study if they were enrolled in first
grade as of September, 1996. Schools were approached one at a time
until the desired sample size was achieved. Since recruitment occurred
within the same area as the CAS, children already participating in the
CAS were excluded from participation in the SCAS. After an introductory
letter explaining the study, parents of eligible children were
contacted by phone by the same research nurse who recruited the CAS
children, and a clinic visit was scheduled. If parents were not
interested in a clinic assessment, the research nurse still attempted
to conduct the telephone interview. Only children coded as "African American" or "European American" were included in this analysis. Races were combined across the two groups to form the final study population (ie, AA children from SCAS and CAS were combined and compared to a combination of EA children from both groups). Prematurity and low birth weight have been associated with asthma.18 The CAS cohort included only "term births" and children with a birth weight > 2,500 g. To increase comparability, this protocol was expanded to the SCAS cohort, in that children with birth weights < 2,500 g were excluded from all analyses.
Clinic Assessments
The clinical assessments for all children were conducted by the
one nurse and two physicians. The series of CAS clinic visits were
completed first, followed immediately by clinic visits for the SCAS
group. The assessments included the following: a medical history and
physical examination, allergen skin testing, spirometry, methacholine
challenge (provocative dose of methacholine causing a 20% fall in
FEV1 [PD20]), and measurement of total and
allergen-specific IgE. An attempt was made to collect a urine specimen
during the clinic assessment for measurement of cotinine and
creatinine. Skin tests were performed by puncture techniques using
commercial (Bayer Pharmaceutical; Spokane, WA) extracts of
Dermatophagoides farinae, Dermatophagoides
pteronyssinus, cat, dog, Alternaria, short ragweed, and bluegrass,
in addition to positive and negative controls of saline solution and
histamine (1 mg/mL). A positive skin test was defined as one with a sum
of perpendicular wheal diameters
4 mm with a larger surrounding
flare.
Spirometry was performed using a KoKo spirometer (Pulmonary Data Service; Louisville, CO) connected to a personal computer. Predicted values were based on the equations of Polgar and included a racial adjustment of 0.8519 . This study focused on FVC and FEV1.
All spirometric assessments were generally performed according to American Thoracic Society standards.20 Spirometry was performed with the children standing and without nose clips. There were two deviations from American Thoracic Society standards. One such deviation occurred when a child could not reproducibly produce maximal peak flows. In these cases, the FEV1 and FVC were given priority and accepted as reproducible if there was < 5% variation in both measures. The second was that some children could not sustain exhalation > 3 s. Since efforts were made to optimize the FEV1 and FVC, these measurements were our primary analytic variables.
Children with initial FEV1 < 70% of predicted were given a bronchodilator (albuterol sulfate by nebulization) and reassessed 15 min later. If a childs initial FEV1 was > 70% of predicted and three maneuvers were reproducible, the child was sequentially challenged with the normal saline diluent and five doses of methacholine (0.025, 0.25, 2.5, 10, and 25 mg/mL) administered with a DeVilbiss 645 nebulizer (DeVilbiss; Bornemouth; England) connected to a French-Rosenthal dosimeter (PDS Instrumentation; Louisville, CO) integrated into the spirometer. The dosimeter was set to deliver methacholine for 0.6 s at the initiation of inhalation during tidal breathing for five breaths. Spirometry was repeated 3 min after each dose of methacholine. Increasing concentrations of methacholine were administered until FEV1 fell to < 80% of the best postsaline solution value or until the maximum concentration was reached. A positive methacholine challenge was defined as a decrease in FEV1 to < 80% of the postsaline solution value following inhalation of methacholine at concentrations up to 10 mg/mL (66 breath units).
Children were classified as having a medical diagnosis of asthma if the parent reported ever being told by a physician that the child had asthma. Current asthma was defined as a physicians diagnosis of asthma and a report of asthma symptoms in the last 12 months.
Laboratory Methods
Total and allergen-specific serum IgE concentrations were
measured using commercially available assays (AlaSTAT; Diagnostic
Products; Los Angeles, CA). Both total and allergen-specific serum IgE
concentrations are expressed in international units per milliliter.
Values of specific IgE
0.35 IU/mL were considered evidence of
detectable antibody as recommended by the manufacturer. The
allergens tested were the same as those listed for skin testing. In
addition, the serum of all SCAS children and a random sample of 116 CAS
children were tested for cockroach-specific IgE. A random sample of
10% of all samples was repeated for quality-control purposes with
> 98% agreement.
Cotinine in the urine was measured by radioimmunoassay by the Clinical Biochemistry Facility, American Health Foundation (Valhalla, NY). Creatinine was also measured to correct for the dilution of the urine. All analyses were performed using the cotinine/creatinine ratio (CCR) as nanograms or cotinine per milligram of creatinine.
Statistical Methods
Comparisons between AA and EA children were done using
Students t test for continuous variables and
2 tests for either nominal or ordinal data. If
cell frequencies were very small, a Fishers Exact test was used in
two-by-two tables. When appropriate, odds ratios (ORs) and
corresponding 95% confidence intervals (CIs) were computed. Multiple
linear regression techniques were used to assess the relationship
between IgE values and airway responsiveness. Logistic regression and
analysis of covariance (ANCOVA) were used to assess the relationship
between race and other variables while adjusting for potential
confounders. A p value < 0.05 was considered to indicate statistical
significance.
As expected, IgE values were positively skewed, and were therefore logarithmically transformed prior to analysis to better fit the assumptions of the various statistical tests.21 After analysis, values were retransformed back to the original units.
To express airway responsiveness to methacholine we used an estimate of
the methacholine dose-response slope as defined by Le Souef et
al.22
This method defines the methacholine slope as
follows:
![]() |
where,
![]() |
| Results |
|---|
|
|
|---|
|
|
The prevalence of physician-diagnosed asthma was similar by race (Table 3 ). A lower percentage of AA children met study criteria for current asthma than EA children, although this difference did not reach statistical significance (3.8% vs 6.7%, respectively).
|
Only 76.9% of AA children had FEV1
70% of
predicted, compared to 99.2% of EA children (Table 3)
. Of the children
with a baseline FEV1 < 70% predicted, only 1
of 15 AA children responded to albuterol, while 3 of 3 EA children
responded (p < 0.01; Table 3
).
ANCOVA was used to further assess the racial difference in baseline percent of predicted FEV1. After adjusting for gender, age, education, parental smoking, and maternal smoking during pregnancy, FEV1 remained significantly associated with race, with the racial difference in adjusted mean percent of predicted FEV1 remaining approximately the same (AA children, 75.3 vs EA children, 93.9; p = 0.001).
Methacholine Reactivity
Approximately 24% of all children challenged had a
PD20
10 mg/mL. AA children were more likely
to respond to methacholine at this dose than EA children (41.7% vs
22.3%, respectively; p < 0.01). Considering possible racial
differences in the acute response to a
ß2-agonist, we compared the
FEV1/FVC ratios of children who had responded by
20% to any dose of methacholine, 15 min after they had received an
albuterol nebulization treatment. No racial difference was found (Table 3)
.
We examined the relationship between race and methacholine reactivity
(PD20
10 mg/mL vs > 10 mg/mL) in a logistic
regression model, adjusting for gender, child age, parental education,
parental smoking, and maternal smoking during pregnancy. The adjusted
OR for the relationship between race and methacholine reactivity was
2.7 (95% CI, 1.4 to 5.4; p = 0.004). Substituting CCR measurements
for reports of parental smoking, the adjusted OR for this relationship
was 3.1 (95% CI, 1.5 to 6.4; p = 0.03).
CCRs
The geometric and logarithmic means for the CCR are presented by
asthma diagnosis and race in Table 4
. Overall, mean CCR was higher for AA children than for EA children.
This trend was observed regardless of asthma diagnosis, although the
racial difference among persons with asthma was not significant (NS),
and among those without a diagnosis, the p value was 0.05. No
statistically significant differences were observed when the geometric
mean CCR for children with and without asthma was compared within
racial categories, (AA with asthma of 18.92 ng/mg vs AA without asthma
of 13.87 ng/mg; p = 0.68; and EA with asthma of 9.58 ng/mg vs EA
without asthma of 11.24 ng/mg; p = 0.001).
|
100 IU/mL were compared, 40.6% vs 16.2% for AA and
EA children, respectively (data not shown).
|
We examined the relationship between race and geometric mean serum IgE using ANCOVA, adjusting for gender, child age, parental education, parental smoking, and maternal smoking during pregnancy. The adjustment for the covariates accentuated the racial difference in geometric mean serum IgE of 26.8 IU/mL for EA children vs 82.2 IU/mL for AA children (p = 0.001). The ANCOVA was then stratified by physician diagnosis of asthma. Results were similar to that of the bivariate analysis. There was no racial difference observed for children with an asthma diagnosis, (geometric mean serum IgE of 175.3 IU/mL for EA children vs 57.9 IU/mL for AA children; p = 0.246) while a significant difference was again observed for those without asthma (geometric mean serum IgE for AA children of 73.2 IU/mL vs 24.5 IU/mL for EA children; p = 0.001).
We also examined the relationship of serum IgE to methacholine reactivity. As shown in Figure 1 , a significant positive relationship was found between methacholine dose-response slopes and total serum IgE concentrations for EA children, (p = 0.001). This relationship was NS (p = 0.73) for AA children. The slopes of the regression lines for the AA and EA children when compared were not significantly different (p = 0.13). When the analysis was done using PD20 instead of the methacholine dose-response slope, similar results were obtained, in that higher total serum IgE concentrations were significantly associated with lower PD20 values for EA children (p = 0.001), but not for AA children (p = 0.44).
|
|
| Discussion |
|---|
|
|
|---|
We conducted our study in a group of middle-class AA and EA children to minimize the confounding effect of SES on the relationships between measures related to asthma severity and race. While racial differences in age and maternal smoking during pregnancy were observed, adjustment for these variables did not dispel the immunologic and physiologic differences found between AA and EA children.
A critical question is the prevalence of asthma in our study compared to other estimates from the United States. The most recent data from the National Health Interview Survey (1993 to 1994) reported a prevalence of asthma symptoms in the preceding 12 months of 7.4% in 5- to 14-year-old children.1 These data were not separated by race within age groups. Previous studies report asthma prevalences from 8 to 14% for children, with urban and minority children being at the higher end of the range.23 24 25 Our 10% prevalence of ever having an asthma diagnosis is consistent with these other estimates, given the methodologic and age differences. The fact that we did not find a higher prevalence of asthma in AA children is partially due to our exclusion of low-birth-weight children. Inclusion of these children from the SCAS group would have increased the AA prevalence from 10.1 to 15% and current asthma from 3.8 to 8%, which are similar to those reported by Crain et al,23 and to the 12.3% prevalence we found in a telephone survey of 8- to 9-year-old children in Southfield.8
We did not observe a positive relationship between methacholine responsiveness and serum IgE in AA children. While failing to find a relationship could be due to the small number of AA subjects, it could also be due to racial differences in the relationship between serum IgE and hyperresponsiveness or asthma. Consistent with the hypothesis of a racial difference is the report by the Collaborative Study on the Genetics of Asthma showing that linkages between chromosomal regions and asthma vary by ethnic group.26
Our findings confirm earlier reports that AA children are significantly more responsive to methacholine than EA children. This relationship was maintained when stratified by parental smoking, the prevalence of which was higher in EA children. It is widely accepted that pulmonary hyperreactivity is a hallmark of asthma, and that greater degrees of hyperreactivity are associated with greater levels of symptoms.27 This may correspond to greater asthma severity among AA children.
We also observed a significant racial difference in total serum IgE. This, too, has been previously reported, but in previous articles, it has been unclear as to whether socioeconomic differences contributed to the difference in serum IgE levels.26 We had anticipated that higher concentrations of total serum IgE would be related to an increased prevalence of IgE specific for common inhalant allergens, especially indoor allergens that have been associated with asthma.28 Racial differences in sensitization were only significant for outdoor allergens. Sensitization to dust mites, cat, dog and cockroach did not differ by race. The differences in the prevalence of sensitization to ragweed and bluegrass are unlikely explanations for the differences in total serum IgE. If environmental factors explained the differences observed, we would expect to see a racial difference in serum specific IgE or in skin test sensitivity for these allergens, and this was not the case. Racial differences in cockroach, Alternaria, and dust mite allergensall traditionally associated with asthmawere not observed. Racial differences in bluegrass were observed, but this is an allergen not usually associated with clinical asthma on a wide scale. Prevalence of parental report of smoking, another indoor irritant, was actually higher for EA compared to AA children, and although this trend was not observed for CCR, the relationship of race to reactivity remained positive and significant after adjustment for these and other adjunct indicators of tobacco smoke exposure, including maternal smoking during pregnancy.
Few studies regarding asthma have included middle-class AA subjects.
This study is one of the first to measure spirometry and methacholine
responsiveness in a study sample of AA and EA children of similar SES.
It is widely recognized that AA subjects have smaller lung capacities
than EA subjects, hence the use of a standardized 15% reduction in the
predicted FVC and FEV1 values for AA children. It
was surprising to find that even after correction for racial
differences, both the average percent predicted FVC and
FEV1 were still significantly lower in the AA
children. This racial difference in lung volumes is demonstrated by the
finding that only 75.9% of AA children had
FEV1
70% of predicted in contrast to 99.2%
of EA children. Study personnel and equipment were the same for all
children. The spirometer was calibrated at the start of each day. There
was no perceptible difference in the cooperation or effort of the
children during spirometry. The difference did not appear to result
from subclinical asthma or airway obstruction, since only one of 15 AA
children with FEV1 < 70% responded acutely to
a bronchodilator, and none of these 15 children had histories
suggestive of asthma. Alternative explanations for this difference
include the imprecision of an estimate based on the relatively small
number of AA children examined, and the possibility that the 15%
correction factor is inadequate. A study of AA and EA adults found that
the between-subject variability in lung function within a racial group
was greater than the difference between races, and suggested that
better predictive methods were needed.29
Unfortunately,
our data cannot help answer the question of whether smaller lung
capacities contribute to more severe asthma.
A potential problem with our study is that we combined two groups of children for analysis. While we feel that the racial differences in the factors we assessed are more likely biological in origin, we cannot totally exclude the possibility of dissimilarity between the two groups, since significant differences in age and parent education were found.
SCAS cohort children averaged about 8 months older than their CAS counterparts. This small differ- ence in age is unlikely to affect our major findings. While serum IgE increases with age, IgE levels do not increase by twofold in a year.30 Others have reported that children become less responsive to methacholine as they become older.31 32 Thus, any effect of the difference in age between the two groups would probably have led to an underestimate of the effects we have presented.
We also observed a significant difference in the educational attainment of parents for the EA children in CAS vs SCAS groups. Education of the parent is a widely used but imperfect indicator of SES.33 34 However, the area from which the second group (SCAS) was drawn is located within the area for recruitment of the initial group (CAS). The objectives of the initial recruitment effort did not include enrollment of a homogeneous group with respect to race; indeed, both African Americans and European Americans were counted among the participants, as were other ethnic groups. To study racial differences, however, the number of AA children in the CAS group was too small. Remaining within that same geographic area, we concentrated our subsequent efforts on neighborhoods we knew to be more racially balanced. Census information from 1990 reports that EA and AA families within the geographic area used for both initial and subsequent recruitment have comparable SES. We note that adjustment for age and parent education did not explain the racial differences observed.
In summary, we found a significant racial difference in the relationship between total serum IgE and airway responsiveness, and between serum IgE and asthma status. To our knowledge, this finding has not been reported in the literature. Our analyses support previously reported racial differences in lung volumes, airway responsiveness, and serum IgE concentrations. These differences are consistent with the hypothesis that AA children may be predisposed to more severe asthma. An alternative hypothesis is that there may be racial differences in factors that predispose to more severe asthma.
More studies of racial differences in factors related to asthma severity are needed with larger populations. Studies of this nature will be instrumental in uncovering the reasons for racial disparities in asthma prevalence and morbidity in this country. Ideal for these assessments would be populations that include large subgroups of major racial classifications, all of which are adequately represented at varying levels of SES.
| Acknowledgements |
|---|
| Footnotes |
|---|
This study was funded by a Fellowship from the National Heart, Lung, and Blood Institute and the National Institute of Allergy and Immunologic Diseases of the National Institutes of Health (Grant AI24156), and by the Henry Ford Health System Medical Treatment Effectiveness Programs (MEDTEP) Research Center on Minority Populations, through Grant U01 HS07386 from the Agency for Health Care Policy and Research.
Received for publication May 26, 1999. Accepted for publication December 28, 1999.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
C. L.M. Joseph, E. L. Peterson, C. C. Johnson, D. R. Ownby, J. C. Celedon, S. T. Weiss, and M. M. Cloutier Racial Differences in Allergen Sensitivity Chest, September 1, 2004; 126(3): 1004 - 1005. [Full Text] [PDF] |
||||
![]() |
E. M. Roberts Does Your Child Have Asthma?: Parent Reports and Medication Use for Pediatric Asthma Arch Pediatr Adolesc Med, May 1, 2003; 157(5): 449 - 455. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Ownby, C. C. Johnson, and E. L. Peterson Exposure to Dogs and Cats in the First Year of Life and Risk of Allergic Sensitization at 6 to 7 Years of Age JAMA, August 28, 2002; 288(8): 963 - 972. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Lemanek, J. Kamps, and N. B. Chung Empirically Supported Treatments in Pediatric Psychology: Regimen Adherence J. Pediatr. Psychol., July 1, 2001; 26(5): 253 - 275. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |